Intercept Pharmaceuticals is a startup based in the United States, most recent round Acquired, 1 tracked investor.
Intercept Pharmaceuticals is a startup founded in 2002 based in the United States. Intercept Pharmaceuticals has been acquired. Brouky records 1 investor associated with the company.
Intercept Pharmaceuticals develops and commercializes therapeutics focused on treating rare and serious liver diseases using proprietary bile acid chemistry and FXR biology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.